Denada Dibra

620 total citations
21 papers, 475 citations indexed

About

Denada Dibra is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Denada Dibra has authored 21 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Denada Dibra's work include Virus-based gene therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Denada Dibra is often cited by papers focused on Virus-based gene therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Denada Dibra collaborates with scholars based in United States and China. Denada Dibra's co-authors include Shulin Li, Xueqing Xia, Jeffry J. Cutrera, Abhisek Mitra, Guillermina Lozano, Arun Satelli, Eugenie S. Kleinerman, Lopa Mishra, Vinod Ravi and Joseph A. Ludwig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Denada Dibra

21 papers receiving 473 citations

Peers

Denada Dibra
Ileana Bortolomai Italy
Cyril Šálek Czechia
Robert Seed United Kingdom
Rie Nakata United States
Katharine D. Grugan United States
Karthik Dhatchinamoorthy United States
Leah Schmidt United States
Todd J. Waldron United States
Joakim Karlsson Sweden
Vidyalakshmi Chandramohan United States
Ileana Bortolomai Italy
Denada Dibra
Citations per year, relative to Denada Dibra Denada Dibra (= 1×) peers Ileana Bortolomai

Countries citing papers authored by Denada Dibra

Since Specialization
Citations

This map shows the geographic impact of Denada Dibra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denada Dibra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denada Dibra more than expected).

Fields of papers citing papers by Denada Dibra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denada Dibra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denada Dibra. The network helps show where Denada Dibra may publish in the future.

Co-authorship network of co-authors of Denada Dibra

This figure shows the co-authorship network connecting the top 25 collaborators of Denada Dibra. A scholar is included among the top collaborators of Denada Dibra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denada Dibra. Denada Dibra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dibra, Denada, Shunbin Xiong, Sydney M. Moyer, et al.. (2024). Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo. Science Advances. 10(7). eadk1835–eadk1835. 22 indexed citations
2.
Dibra, Denada, Lalit R. Patel, Shunbin Xiong, et al.. (2024). p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator. Cancer Research Communications. 4(8). 1991–2007. 1 indexed citations
3.
Dibra, Denada, Mihai Gagea, Yuan Qi, et al.. (2023). p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver Tumorigenesis. Cancer Research Communications. 3(12). 2640–2652. 1 indexed citations
4.
Dibra, Denada, Sydney M. Moyer, Adel K. El‐Naggar, et al.. (2023). Triple-negative breast tumors are dependent on mutant p53 for growth and survival. Proceedings of the National Academy of Sciences. 120(34). e2308807120–e2308807120. 15 indexed citations
5.
Dibra, Denada, Xueqing Xia, Mihai Gagea, Guillermina Lozano, & Shulin Li. (2018). A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53. PLoS ONE. 13(3). e0193485–e0193485. 8 indexed citations
6.
Dibra, Denada, Abhisek Mitra, Xueqing Xia, et al.. (2016). Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo. Clinical Cancer Research. 22(15). 3876–3883. 12 indexed citations
7.
Dibra, Denada, Abhisek Mitra, Xueqing Xia, et al.. (2016). IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin. Oncotarget. 7(47). 77138–77151. 5 indexed citations
8.
Yan, Jun, Ling-Yuan Kong, Jiemiao Hu, et al.. (2015). FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas. JNCI Journal of the National Cancer Institute. 107(8). 80 indexed citations
9.
Dibra, Denada, Xueqing Xia, Abhisek Mitra, et al.. (2015). Mutant p53 in concert with an interleukin‐27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice. Hepatology. 63(3). 1000–1012. 29 indexed citations
10.
Satelli, Arun, Abhisek Mitra, Jeffry J. Cutrera, et al.. (2014). Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells. Cancer Research. 74(6). 1645–1650. 131 indexed citations
11.
Dibra, Denada, Lopa Mishra, & Shulin Li. (2014). Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: An underappreciated symbiotic relationship. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846(1). 152–160. 15 indexed citations
12.
13.
Cutrera, Jeffry J., et al.. (2013). Intricacies for Posttranslational Tumor-Targeted Cytokine Gene Therapy. Mediators of Inflammation. 2013. 1–9. 4 indexed citations
14.
Dibra, Denada, et al.. (2013). Abstract 1430: The role of IL27 as a driver of skin carcinogenesis.. Cancer Research. 73(8_Supplement). 1430–1430. 1 indexed citations
15.
Dibra, Denada, Jeffry J. Cutrera, & Shulin Li. (2012). Coordination between TLR9 Signaling in Macrophages and CD3 Signaling in T Cells Induces Robust Expression of IL-30. The Journal of Immunology. 188(8). 3709–3715. 20 indexed citations
16.
Cutrera, Jeffry J., Denada Dibra, Xueqing Xia, et al.. (2011). Discovery of a Linear Peptide for Improving Tumor Targeting of Gene Products and Treatment of Distal Tumors by IL-12 Gene Therapy. Molecular Therapy. 19(8). 1468–1477. 43 indexed citations
17.
Dibra, Denada, Jeffry J. Cutrera, Xueqing Xia, & Shulin Li. (2011). WSX1 Expression in Tumors Induces Immune Tolerance via Suppression of Effector Immune Cells. PLoS ONE. 6(4). e19072–e19072. 8 indexed citations
18.
Dibra, Denada, Jeffry J. Cutrera, Xueqing Xia, et al.. (2011). Interleukin-30: A novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury. Hepatology. 55(4). 1204–1214. 38 indexed citations
19.
Cutrera, Jeffry J., et al.. (2009). Enhancement of reporter gene detection sensitivity by insertion of specific mini-peptide-coding sequences. Cancer Gene Therapy. 17(2). 131–140. 5 indexed citations
20.
Dibra, Denada, Jeffry J. Cutrera, Xueqing Xia, Mark Birkenbach, & Shulin Li. (2009). Expression of WSX1 in Tumors Sensitizes IL-27 Signaling-Independent Natural Killer Cell Surveillance. Cancer Research. 69(13). 5505–5513. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ileana Bortolomai Breakdown of academic impact, for papers by Cyril Šálek Breakdown of academic impact, for papers by Robert Seed Breakdown of academic impact, for papers by Rie Nakata Breakdown of academic impact, for papers by Katharine D. Grugan Breakdown of academic impact, for papers by Karthik Dhatchinamoorthy Breakdown of academic impact, for papers by Leah Schmidt Breakdown of academic impact, for papers by Todd J. Waldron Breakdown of academic impact, for papers by Joakim Karlsson Breakdown of academic impact, for papers by Vidyalakshmi Chandramohan
Rankless by CCL
2026